Assistance Listing 93.396
Department of Health and Human Services · National Institutes of Health
Assistance Listing 93.396, “Cancer Biology Research,” is a federal program administered by Department of Health and Human Services. It provides grant and cooperative agreement assistance. GrantsJunction currently tracks 28 open, 8 forecasted and 4 closed opportunities under this listing. The agency reported $936M in obligations for fiscal year 2025.
To provide fundamental information on the cause and nature of cancer in people, with the expectation that this will result in better methods of prevention, detection and diagnosis, and treatment of neoplastic diseases. Cancer Biology Research includes the following research programs: cancer cell biology; cancer immunology, hematology and etiology; DNA and chromosomal aberrations; tumor biology and metastasis; and structural biology and molecular applications.
As published in the SAM.gov Assistance Listing.
The awardee will be a university, college, hospital, public agency, nonprofit research institution or for-profit organization that submits an application and receives a grant for support of research by a named principal investigator. To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Intended beneficiaries: Graduate Student, Scientist/Researchers, Public nonprofit institution/organization, Health Professional, Private nonprofit institution/organization and Student/Trainee.
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Range and average of financial assistance (from the listing): Range: $4,800 to $3,144,604 Average: $490,440
Source: SAM.gov Assistance Listing 93.396. Hatched bars are agency estimates. These totals do not indicate approval rates.| Opportunity | Status | Award range | Closes | ALN |
|---|---|---|---|---|
Metastasis Research Network (U54 Clinical Trial Not Allowed)National Institutes of Health | Closed | Up to $1.3M | Sep 25, 2026 | 93.396 |
| Closed | Up to $499K | Sep 7, 2026 | 93.393, 93.394, 93.395, 93.396 | |
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)National Institutes of Health | Closed | Amount not specified | Jan 8, 2026 | 93.121, 93.233, 93.242, 93.279, 93.313, 93.393, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.866 |
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)National Institutes of Health | Closed | Amount not specified | Jan 8, 2026 | 93.121, 93.233, 93.242, 93.279, 93.313, 93.393, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.866 |
93.396 is the Assistance Listing Number for “Cancer Biology Research.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
The SAM.gov listing names these applicant types: Tribal, Nonprofit Organization, State, Not-for-Profit Organization, International Organization, Territorial, Local and For-Profit Organization. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
The agency reported $935,620,177 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.